Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gynatrof MenoControl is a non-hormonal, estrogen-free oral menopause-support dietary supplement developed by Tyros Biopharma. It is formulated as a once-daily capsule combining the proprietary botanical complex Estro-G® (EstroG-100®)—which consists of hot-water extracts of *Angelica gigas*, *Cynanchum wilfordii*, and *Phlomis umbrosa* roots—with vitamins B6, B12, D, and folate. Gynatrof MenoControl is designed to relieve multi-symptom menopause discomforts, including hot flashes, night sweats, sleep disturbances, fatigue, mood imbalance, joint discomfort, and vaginal dryness, without exhibiting estrogenic activity or binding to estrogen receptors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Gynatrof MenoControl.